As part of the buildup to Insulin Safety Week 2024, a recent webinar proved a resounding success, attracting healthcare professionals from across the UK and Ireland to increase their understanding of the latest advancements in diabetes technology.
With just six weeks to go until Insulin Safety Week returns, over 500 healthcare professionals registered to take part in last week’s webinar focusing on recent advancements in diabetes technology that are revolutionising the management of diabetes during pregnancy and beyond.
Led by Dr Helen Murphy Professor of Medicine at the University of East Anglia, and a practicing clinician, and Dr Tara Lee, Clinical Research Fellow at the University of East Anglia and the Norfolk and Norwich University Hospitals NHS Foundation Trust, the interactive session helped attendees understand which hybrid closed loop systems offer the most significant clinical advantages for both mothers and babies.
Following recent NICE technology appraisal guidance on hybrid closed loop systems, Insulin Safety Week 2024 aims to ensure diabetes experts and non-specialists are fully prepared for the phased roll out, reducing challenges around insulin safety.
Open to all healthcare professionals working in diabetes care, the nationwide campaign, held from Monday, July 1, to Sunday, July 7, will provide comprehensive printed and online resources to help increase understanding of the new technology. Following fantastic feedback from those attending the recent webinar, a recording of it will be included in the campaign resource packs.
Event manager Emily Mayhew said: “We are delighted to share that nearly 400 healthcare sites have registered to take part in Insulin Safety Week 2024.
“This campaign is an important opportunity for nurses, doctors, and other healthcare staff to come together and increase their understanding of the safe use of technology, helping to reduce insulin errors and improve patient outcomes.”
Another educational webinar is planned for Wednesday, July 3, which will be delivered by the DISN UK Group, and will aim to enhance attendees understanding of effective use of diabetes technology, including insulin pumps, Continuous Glucose Monitors (CGM) and Point-of-Care Testing (POCT), when treating inpatients with diabetes.
Free to attend, healthcare professionals can book their place on the webinar here.
To register and receive your resource pack, email registrations@ojpr.co.uk with the following information:
- Lead organiser’s name
- Name of trust/organisation
- Number of participating sites (including names of each)
- Telephone number
- If you require t-shirts and amount (up to four)
Insulin Safety Week 2024 is organised by Orange Juice Communications and has been funded by Dexcom, Embecta, GlucoRx, Medtronic, Sanofi and Ypsomed which have had no input into any arrangements or content.
For more information about Insulin Safety Week 2024, visit www.insulinsafetyweek.com.